Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0E9XR
|
|||
| Drug Name |
STP705
|
|||
| Indication | Basal cell carcinoma [ICD-11: 2C32; ICD-10: C44] | Phase 2 | [1] | |
| Hypertrophic scars [ICD-11: EE60; ICD-10: L73.0] | Phase 1/2 | [2] | ||
| Company |
Sirnaomics Gaithersburg, MD
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04669808) Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With Basal Cell Carcinoma. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.